Posted by Michael Wonder on 07 Apr 2026
ICER releases draft evidence report on vaccines for Covid-19
7 April 2026 - Public comment period now open until 4 May 2026; requests to make oral comment during public meeting also being accepted.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of Comirnaty (Pfizer, BioNTech), Spikevax (Moderna), mNexspike (Moderna), and Nuvaxovid (Sanofi) for the protection against Covid-19, including both the short- and long-term effects of the infection.
